använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

Equity Research


Commissioned research by Vator Securities is offered to selected life science companies – “By Invitation Only”


Commissioned research: Immunovia AB

1 April 2019

Immunovia is a Swedish-based diagnostic company in late-stage development for products for early detection of diseases within the oncology and autoimmune areas, with a primary target on early detection of pancreas cancer.

The company’s management team has extensive diagnostics company background, including GE Healthcare and DAKO (aquired by Agilent)

Commissioned research: AlzeCure Pharma

15 January 2019

AlzeCure Pharma is a Swedish-based pharmaceutical company with potentially first-in-class proprietary and novel targeted small molecule (tablets) candidates for neurodegenerative diseases with a primary target on Alzheimer’s Disease (AD).

AlzeCure’s management team has extensive big pharma experience, and formed an integral part of AstraZeneca’s CNS department.